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Silica nanotubes (SNTs) functionalized with magnetic and up-conversion luminescent (UCL) NaYF4:Yb/Er/
Gd nanocrystals (NCs) (denoted as MUCNCs@SNTs) have been prepared by single-nozzle electrospinning
based on a phase separation effect without any templates. Monodisperse and hydrophilic cubic
a-NaYF4:Yb/Er/Gd NCs decorated with polyethyleneimine (PEI) were fabricated in a facile hydrothermal
route. Then, the Gd3+-doped a-NaYF4:Yb/Er NCs were dispersed into the electrospinning precursor
solution containing polyvinylpyrrolidone (PVP) and tetraethylorthosilicate (TEOS), followed by the
preparation of precursor nanotubes via electrospinning process. Finally, after annealing at 600 uC, pure
MUCNCs@SNTs were obtained. The biocompatibility test on L929 fibroblast cells using MTT assay reveals
low cytotoxicity of the composites. Doxorubicin hydrochloride (DOX), a typical anti-cancer drug, was
introduced into MUCNCs@SNTs to evaluate the loading and sustained release behaviours. The composite
carriers provide pH-dependent drug release behaviour owing to abundant Si–OH active bonds of silica and
its interactions with DOX. The in vitro cytotoxicity and cell uptake behaviour of the MUCNCs@SNTs for
HeLa cells were evaluated. For in vitro magnetic resonance imaging (MRI), the composites show the
promising spin lattice relaxation time (T1) weighted effect and could potentially apply as a T1-positive
contrast agent. In addition, the composites show near-infrared UC luminescence and were successfully
applied in the bioimaging of HeLa cells. Considering the good biocompatibility, high drug releasing
content and pH-dependent drug release of the materials, these magnetic and luminescent composite
nanotubes have potential applications in drug sustained release and magnetic resonance/UC
luminescence modality imaging.
Introduction
Now much attention has been paid to novel drug-storage/
release systems in the fields of modern medicine and
pharmaceuticals, due to their numerous advantages over
traditional forms of dosage, such as enhanced bioavailability,
controlled and prolonged released time, greater efficacy and
safety, and predictable therapeutic response.1–3 Normally, an
ideal drug-delivery system (DDS) should not only protect the
drug from biological degradation before reaching the target
organs or cells, but also provide a sustained controlled release
in the physiological condition.4–7 So far, a series of inorganic
biomaterials such as hydroxyapatite (HAp),8,9 calcium phos-
phate cement (CPC),10,11 bioactive glasses,12–14 biocera-
mics,15,16 xerogels,17 and calcium silicate18,19 have been
successfully exploited in sustained/controlled drug delivery
based on their improved drug loading efficiency and degrad-
able properties. However, the amount of drug release has been
one limitation in the DDSs above. In consideration of different
nanostructures of DDSs, inorganic nanotubes may solve the
problem while the inner void can take up a large amount of
drugs, and the open ends of pores serve as gates that can
control the release of drugs.20,21
Among those tubular nanomaterials, silica nanotubes
(SNTs) have aroused wide concern because of their hydrophilic
nature, easy colloidal suspension formation, and surface
functionalization accessibility for both inner and outer
walls.22–24 The general strategy for the synthesis of hollow
structures is a template-assisted process which tends to be
rather complicated, with the obvious drawback that the
removal process often compromises the structural integrity
of the final products and limits the practical applications.
Therefore it is necessary and important to develop an easy and
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direct method to fabricate highly purified SNTs. During the
past decade, the electrospinning technique has become one of
the most frequently-used methods to fabricate one dimen-
sional nanostructures at low cost.25,26 Here, single-nozzle
electrospinning based on a phase separation effect without
any templates was brought up to fabricate nanotube structure.
To the best of our knowledge, silica tubes functionalized with
photoluminescence (PL) via an electrospinning process have
never been really tested as DDSs to demonstrate their potential
application. Self-activated SNTs show auto-fluorescence under
short-wavelength ultraviolet (UV) radiation, which greatly
decrease the signal-to-noise and detection sensitivity.
Compared with the conventional down-conversion process,
up-conversion (UC) luminescent materials have many advan-
tages after being excited by lower-energy near-infrared (NIR)
photons, such as greater tissue penetration, weak autofluor-
escence from cells or tissues, and high signal-to-noise ratio.27–34
As a result, rare earth up-conversion nanophosphors accom-
panied with many advantages, such as the use of non-invasive
NIR radiation and the absence of autofluorescence, have been
applied in photoluminescence bioimaging exhibit.35,36
However, photoluminescent imaging has one shortcoming of
the low penetration depth of the excitation and emission light,
and this can be solved by magnetic resonance imaging
(MRI).37,38 Therefore, the design and development of silica
nanotubes functionalized with magnetic and UC luminescent
properties as drug carriers are undoubtedly of great importance
in the field of drug delivery and modality imaging.39,40
Unfortunately, little attention has been paid to this area so far.41
As a continuation of our former research of drug storage/
release,42–45 in this paper, we intend to prepare NaYF4:Yb/Er/
Gd (the efficient NIR-to-visible UC material46–49)-decorated
SNTs as DDS via the electrospinning method. By introducing
Gd3+ in the host matrix, magnetic and UC luminescent
NaYF4:Yb/Er/Gd NCs (MUCNCs) have successfully been fabri-
cated for dual modal imaging of T1-enhanced magnetic
resonance and UC luminescence. Firstly, hydrophilic cubic
a-NaYF4:Yb/Er/Gd NCs decorated with PEI which could control
the growth of the crystals were fabricated by a facile
hydrothermal route.50 Then, the MUCNCs were dispersed into
electrospinning solution, followed by the preparation of
precursor hybrid tubes containing MUCNCs via electrospin-
ning process. Finally, after annealing at 600 uC,
MUCNCs@SNTs were obtained. The biocompatibility test on
L929 fibroblast cells using the MTT assay reveals the low
cytotoxicity of the system. The obtained materials have been
studied as a DDS by using doxorubicin hydrochloride (DOX) as
a model drug. The drug loading and releasing properties,
cytotoxicity, and cellular uptake behavior were examined in
detail. Furthermore, the effectiveness of MUCNCs@SNTs
composites as a multifunctional bioprobe has been demon-
strated by in vitro magnetic resonance/UC luminescence
modality imaging.
Experimental section
Chemicals and materials
Tetraethyl orthosilicate (TEOS, analytical reagent, A. R.) were
purchased from Beijing Yili Fine Chemicals Co., Ltd.
Polyvinylpyrrolidone (PVP, Mw = 1 300 000) and polyethylenei-
mine (PEI, branched polymer (–NHCH2CH2–)x(–N(CH2CH2NH2)
CH2CH2–)y) were purchased from Aldrich. DOX was obtained
from the Nanjing Duodian Chemical Limited Company. The
rare earth oxides RE2O3 (99.99%) (RE = Y, Yb, Er, Gd) were
purchased from Science and Technology Parent Company of
Changchun Institute of Applied Chemistry and other chemicals
were purchased from Beijing Chemical Co., Ltd. YbCl3, ErCl3,
GdCl3 and YCl3 crystals were prepared by dissolving corre-
sponding oxides in hydrochloric acid and heating, then
dissolved in ethylene glycol (0.5 M). All chemicals are of
analytical grade reagents and used directly without further
purification.
Synthesis of water-dispersible PEI coated MUCNCs
In a typical procedure for preparing NaYF4 particles, 0.2 g PEI,
1.2 mmol of NaCl and 1.2 mL RECl3 (0.5 M, RE: 72%Y
3+,
17%Yb3+, 3%Er3+, 8% Gd3+ mole ratio) were first added into
7.8 mL of ethylene glycol under vigorous stirring until forming
a transparent solution. Subsequently, 3.6 mmol NH4F was
added into 9 mL ethylene glycol. After vigorous stirring for 15
min, the two solutions above were mixed together, and then
transferred into a 50 mL Teflon autoclave, which was tightly
sealed and maintained at 200 uC for only 1 h. As the autoclave
was cooled to room temperature naturally, the NCs obtained
were collected by centrifugation, washed three times with
ethanol and deionized water, and finally dispersed in 5 mL
H2O.
Synthesis of magnetic and UC luminescent MUCNCs@SNTs
Magnetic and UC luminescent functionalized silica nanotubes
were prepared by electrospinning using TEOS as silicon
source. 2 mL TEOS was mixed with 0.1 mM PVP solution in
ethanol. Then 2.5 mL of water soluble MUCNCs solution was
added drop by drop under vigorous stirring. 2 h later, the
mixture was transferred into a single-nozzle electrospinning
setup. The distance between the spinneret (a metallic needle)
and the collector (a grounded conductor) was fixed at 15 cm
and the high-voltage supply was maintained at 8 kV. The
spinning rate was controlled at 1.0 mL h21 by a syringe pump
(TJ-3AW/0109-1B, Baoding Longer Precision Pump Co., Ltd,
China). The as-spun fibers were collected on the collector.
After electrospinning, these precursor PVP/TEOS fibers were
placed in a Petri dish and dried for more than 1 day. The as-
prepared hybrid precursor samples annealed in an air atmo-
sphere at 200 uC for 2 h and then calcined in air at 600 uC for 3
h with the heating rate of 2 uC min21. Finally, pure
MUCNCs@silica hollow tubes were obtained.
The biocompatibility of the MUCNCs@SNTs
To evaluate the biocompatibility of the MUCNCs@SNTs, MTT
cell assay was used on the L929 cell. MTT is a standard test for
screening the toxicity of biomaterials and is carried out in
accordance with ASTM standards. This method is based on the
8518 | RSC Adv., 2013, 3, 8517–8526 This journal is  The Royal Society of Chemistry 2013
Paper RSC Advances
Pu
bl
ish
ed
 o
n 
20
 M
ar
ch
 2
01
3.
 D
ow
nl
oa
de
d 
by
 L
ib
ra
ry
 o
f C
hi
ne
se
 A
ca
de
m
y 
of
 S
ci
en
ce
s o
n 
15
/0
3/
20
14
 0
8:
34
:3
0.
 
View Article Online
formation of dark red formazan by the metabolically active
cells after their exposure to MTT[3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide]. Briefly, plate 5000–6000
L929 fibroblast cells in 100 mL media per well in a 96 well
plate. Incubate (37 uC, 5% CO2) overnight to allow the cells to
attach to the wells. The MUCNCs@SNTs were sterilized by
ultraviolet irradiation for 2 h, and then serial dilutions of the
nanocomposites at concentrations of 3.125, 6.25, 12.5, 25, 50,
100 and 200 mg mL21 were added to the culture wells and
incubated for another 24 h in 5% CO2 at 37 uC. 5 mg mL
21
stock solution of MTT was prepared in PBS and this stock
solution (20 mL) was added to each well containing a different
amount of the monodisperse MUCNCs@SNTs. The plate was
incubated at 37 uC for 4 h. During this period viable cells
reduce MTT to formazan pigment, which can be dissolved by
dimethyl sulfoxide (DMSO). The supernatant in each well was
aspirated. After incubation, 150 mL of DMSO was added to
each well, and placed on a shaking table, 150 rpm for 5 min, to
thoroughly mix the formazan into the solvent. The absorbance
of the suspension was recorded under a microplate reader
(Thermo Multiskan mk3) at 490 nm.
Preparation of drug storage/delivery systems
10 mg of UCNCs@SNT samples dispersing in 0.5 mL water
were mixed with 2 mL of DOX aqueous solution (1 mg mL21).
After stirring for 24 h under dark conditions, the DOX-loaded
samples were collected by centrifugation and denoted as DOX-
MUCNCs@SNTs. Then, DOX-MUCNCs@SNTs were transferred
to a dialysis tube and immersed in 2 mL pH = 7.4 and 5
phosphoric acidic buffer solutions (PBS) at 37 uC with gentle
shaking. At predetermined time intervals, PBS was taken by
centrifugation and replaced with an equal volume of fresh
PBS. The amounts of released DOX in the supernatant
solutions were measured by UV-vis spectrophotometer at a
wavelength of 480 nm. To evaluate the DOX-loading efficiency,
the supernatant and washed solutions were collected and the
residual DOX content (RDOX) was obtained by UV-vis measure-
ment at a wavelength of 480 nm. The loading efficiency of DOX
can be calculated as follows: [(ODOX 2 RDOX)/ODOX]6 100%, in
which ODOX is the original DOX content.
In vitro cytotoxicity of DOX-MUCNCs@SNTs against HeLa cells
HeLa cells were plated out in 96-well plates at a density of 8000
cells per well and were allowed to attach and grow for 24 h to
allow the cells to attach. The free DOX, DOX-MUCNCs@SNTs,
and MUCNCs@SNTs were added to the medium, and the cells
were incubated in 5% CO2 at 37 uC for 24 h. The concentra-
tions of DOX were 1.5625, 3.125, 6.25, 12.5, 25, 50 mg mL21
respectively and the correlative concentrations of SNTs were
17.1875, 34.375, 68.75, 137.5, 275, 550 mg mL21, respectively.
Before removing the media in the tubular composites, 20 mL of
MTT solution was added into each cell and incubated for
another 4 h. The supernatant in each well was aspirated and
150 mL of DMSO was added to each well before the plate was
examined using a microplate reader (Therom Multiskan MK3)
at the wavelength of 490 nm.
Cellular uptake of the MUCNCs@SNTs
MUCNCs@SNTs composite materials were ultrasonically
treated before cellular uptake and modality imaging. Cellular
uptake by HeLa cells was examined using flow cytometry.
FITC-labeled MUCNCs@SNTs were synthesized firstly. 2 mg
FITC and 45 mL APTMS were dissolved in 1 mL ethanol and
stirred at room temperature for 12 h in the dark. Then 20 mL
above solution and 20 mg SNTs were added into 20 mL
ethanol, and the mixture was refluxed at 80 uC for another 12
h. The composites were separated by centrifugation, washed
with ethanol and dialysis against water (cutoff molecular
weight: 8000–10 000 Da). For flow cytometry studies, HeLa
cells (1 6 106) were seeded in 6-well culture plates and grown
overnight. The cells were then treated with FITC-labeled
MUCNCs@SNTs at 37 uC for 30 min and 6 h. A single cell
suspension was prepared consecutively by trypsinization,
washing with PBS, and filtration through 35 mm nylon mesh.
Thereafter, the cells were lifted using a cell stripper (Media
Tech. Inc.), and analyzed using a FACSCalibur flow cytometer
(BD Biosciences) for FITC. The excitation wavelength and
emission wavelength were 488 nm and 525 nm, respectively.
MR imaging of the MUCNCs@SNTs
The T1-weighted MR images were obtained using a 0.55 T MRI
magnet (Shanghai Niumag Corporation Ration NM120-
Analyst). Dilutions of MUCNCs@SNTs (Gd concentration:
0.025, 0.125, 0.25, 0.5, 1 mM) in deionized water were placed
in a series of 2 mL tubes for T1-weighted MR imaging. The
following parameters were adopted: TR/TE (repetition time/
echo time) = 500/12 ms, FOV (field of view in cm) = 1006 100,
slice thickness = 4.9 mm.
UC luminescence imaging of the UCNCs@SNTs
The instrument of up-conversion luminescence microscopy
(UCLM) was rebuilt on an inverted florescence microscope
(Nikon Ti-S), an infrared laser excited unit (FF735-Di01-25 6
36, Nikon) and laser diode driver (KS3-11312-312, BWT). UC
luminescence (UCL) bioimaging of HeLa (5 6 104/well) were
seeded in 6-well culture plates (a clean cover slip was put in
each well) and grown overnight as a monolayer, and were
incubated with DOX-MUCNCs@SNTs at 37 uC for 4 h.
Thereafter, the cells were washed with PBS three times, fixed
with 2.5% formaldehyde at 37 uC for 10 min, and then washed
with PBS three times again. UCLM imaging was performed
with the reconstructive Nikon Ti–S. Cells were excited by
infrared laser at 980 nm (BWT Beijing LTD, China) with output
power of 250 mW.
Characterization
The X-ray diffraction (XRD) patterns of the samples were
carried out on a D8 Focus diffractometer (Bruker) with use of
Cu-Ka radiation (l = 0.15405 nm). The UV-vis adsorption
spectral values were measured on a U-3310 spectrophot-
ometer. The morphology of the samples was inspected using
a field emission scanning electron microscope (Philips XL 30).
Transmission electron microscopy (TEM) micrograph was
obtained from a FEI Tecnai G2 S-Twin transmission electron
microscope with a field emission gun operating at 200 kV.
This journal is  The Royal Society of Chemistry 2013 RSC Adv., 2013, 3, 8517–8526 | 8519
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Nitrogen adsorption/desorption analysis was measured using
a Micromeritics ASAP 2020 M apparatus. The specific surface
area was determined by the Brunauer-Emmett-Teller (BET)
method using the data between 0.05 and 0.35. The pore
volume was obtained from the t-plot method. The UC emission
spectra were obtained using a 980 nm laser diode as the
excitation source and the emission spectra were dispersed by
the emission monochromator of the Acton SpectraPro-2758
equipped with R928 PMT, and the data were recorded from
400 to 700 nm. The photos of up-conversion luminescence
were obtained digitally on a Nikon multiple CCD camera (DS-
Ri1). A flow cytometry (FCM, BD Biosciences) with an
excitation wavelength of 488 nm was used to quantify the
transfection efficiency of each sample.
Results and discussion
Structure, morphology and formation of the nanocomposites
Fig. 1 shows the XRD patterns of the as-synthesized NaYF4:Yb/
Er/Gd and NaYF4:Yb/Er/Gd@SiO2 nanocomposites, as well as
the JCPDS cards for NaYF4, respectively. In Fig. 1a for samples
obtained by the hydrothermal method, all the diffraction
peaks can be indexed as a pure cubic a-phase of NaYF4, which
agrees well with the reference values (JCPDS No. 77-2042).
When the electrospun precursor samples are calcined at 600
uC, a broad peak centered at 2h = 22u can be observed due to
the characteristic reflection from amorphous SiO2 (JCPDS No.
29-0085). The other sharp diffraction peaks are in good
agreement with those of cubic a-phase structure known from
bulk a-NaYF4 phase (JCPDS No. 77-2042) as shown in Fig. 1b.
Fig. 2a shows the TEM image of the NaYF4 NCs co-doped
with 17% Yb3+, 3% Er3+ and 8% Gd3+ using PEI as a surfactant,
and it can be seen that the NCs exhibit spherical shape with an
average size about 30 nm. The corresponding HR-TEM
(Fig. 2b) image clearly shows lattice fringes with interplanar
spacing of 0.315 nm ascribed to the (111) plane of a-NaYF4.
PEI contains a large number of amino groups in the long
molecular chain, which are capable of binding to the
nanocrystal surface more tightly and thus it is more efficient
to control the particle growth and stabilize the particles
against aggregation (Fig. S1a, ESI3).51 As can be seen in Fig.
S1b, ESI3, without the addition of PEI, NCs with irregular
shape and nonuniform size were produced. The UC emission
spectrum and luminescent photograph of the as-synthesized
a-NaYF4:Yb/Er/Gd NCs are shown in Fig. 2c. In the emission
spectrum for a-NaYF4:Yb/Er/Gd NCs, the spectral peaks can be
observed corresponding to the electron transitions of Er3+
ions: 2H11/2/
4S3/2 A 4I15/2 (from 510 to 575 nm), 4H9/2 A 4I15/2
(660 and 675 nm),52,53 whose emission peaks are similar to
those observed in previous study for the pure UC crystals.54
The insets of Fig. 2c give the digital photograph of
a-NaYF4:Yb
3+, Er3+ NCs dispersed in ethanol and the corre-
sponding luminescent photograph under 980 nm NIR laser
excitation. The results demonstrate the as-synthesized
a-NaYF4:Yb/Er/Gd NCs (MUCNCs) can be well dispersed in
above solution and emit red light.
The morphology and structure of the electrospun precursor
samples and NaYF4:Yb/Er/Gd@SiO2 nanocomposites were
investigated by SEM and TEM observations. Fig. 3 shows the
Fig. 1 XRD patterns of the PEI coated a-NaYF4:Yb/Er/Gd NCs (a) and NaYF4:Yb/
Er/Gd@SiO2 nanocomposites (b), as well as the JCPDS cards for NaYF4,
respectively.
Fig. 2 TEM (a) and HR-TEM (b) images of PEI coated a- NaYF4:Yb/Er/Gd NCs, UC
emission spectrum and luminescent photograph of the NCs (c).
Fig. 3 SEM (a) and TEM (b) images of as-synthesis MUCNCs@precursor fibers.
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SEM (a) and TEM (b) micrographs of as-prepared electrospun
precursor samples. It can be found that a hollow structure had
already formed within the samples after drying. The MUCNCs
are dispersed uniformly in the hollow fibers. The typical
average diameter of the hollow fibers is about 1.5 mm with a
rough outer and inner surface as seen in the inset of Fig. 3a.
The rough inner wall might be caused by the rapid phase
separation during the electrospinning process. The length of
these hollow fibers can reach up to the millimeter scale, which
is similar to the silica fibers prepared by electrospinning with
TEOS sol–gel.55,56 In order to remove the PVP and obtain pure
SNTs, the dried composite hollow fibers were calcined in air at
600 uC for 3 h. As shown in the SEM image (Fig. 4a), the outer
diameter of the hollow fibers decreases to about one half of
that of the precursor fibers. This reduction of the fiber
diameters might be attributed to two aspects. First, PVP was
completely decomposed during the high temperature anneal-
ing treatment, leaving many vacancies in the tube walls,
accordingly resulting in the shrinkage of the tubes during 600
uC calcination process. On the other hand, silica molecules
and MUCNCs could reconfigure in the tube walls at high
temperature, which not only led to the rough surfaces of the
tubes, but also to the shrinkage of the tubes. It can be clearly
seen that the electrospun samples are comprised of tubular
fibers with wall thickness of 75–150 nm and the outer
diameters of the products range from 500 nm to 1 mm. The
morphology of the MUCNCs@SNTs is further characterized by
TEM and HR-TEM techniques. The tubular morphology can be
clearly seen from the result of TEM due to the different
electron penetrability for the edge and middle of the tubes,
and the wall thickness is about 95 nm as shown in Fig. 4b.
From the high-magnification of TEM image (Fig. 4c), it can be
seen that a-NaYF4:Yb/Er/Gd NCs also disperse uniformly in the
MUCNCs@SNTs after calcination. Moreover, the obvious
lattice fringes in the HR-TEM image (in Fig. 4d) confirm the
high crystallinity of a-NaYF4:Yb/Er/Gd NCs in the SNTs after
high temperature annealing. The distance of 0.315 nm
between the adjacent lattice fringes of MUCNCs@SNTs is well
consistent with the d111 spacing (0.315 nm) of the cubic
a-NaYF4 (JCPDS No. 77-2042).
The possible formation process of the MUCNCs@SNTs is
schematically shown in Fig. 5. The as-synthesized 30 nm-sized
UCNCs coated with PEI are typically dispersible in various
solvents including water, ethanol, dimethylformamide,
dimethylsulphoxide and ethylene glycol which can be con-
ducted in the electrospinning experiment directly. To illumi-
nate the formation of tubular morphology in a polymer-solvent
system, theoretical analysis and simulations have been
contributed by Dayal and Kyu.57 The fiber morphologies have
been well demonstrated in terms of the phase diagram of the
polymer solution, which in a manner depends on the
competition between the phase separation dynamics and the
evaporation rate of solvent.58 During the electrospinning
process, once the fibers were spun out from the nozzle, the
ethanol solvent will evaporate rapidly from the fibers. Then,
PVP would be forced to emigrate from the core of the fibers to
the outer surface due to its incompatibility with TEOS.
Accordingly, the TEOS-(PVP/silica) containing MUCNCs core-
shell composite nanofibers were obtained (TEOS as the core
and PVP/silica composite as the shell). On the other hand,
TEOS is a volatile liquid, which might evaporate through the
walls of the nanotubes easily. Accordingly, PVP/silica Fig. 3a),
Fig. 4 SEM (a), TEM (b, c) and HR-TEM (d) images of 600 uC annealing derived
MUCNCs@SiO2 nanotubes.
Fig. 5 Schematic diagram of the formation mechanism of SiO2 nanotubes. Silica, grey; TEOS, blue; PVP, red. The ethanol concentration decreases from blue to white.
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and the roughness of the wall is evidence of rapid phase
separation during the electrospinning process, which is
similar to the formation of nanoporous nanofibers. After
annealing at a temperature above 600 uC, PVP molecules
would be decomposed and removed completely from the
composite nanotubes and MUCNCs could reconfigure in the
tube walls.
In the work, we can confirm the entire removal of PVP by FT-
IR. The FT-IR spectra of MUCNCs@precursor fibers (a) and
pure MUCNCs@SNTs (b) are shown in Fig. S2, ESI3,
respectively. In Fig. S2a, ESI3, for the as-formed precursor
samples, the FT-IR spectrum shows the –OH group (3425
cm21), –CH2 group (2957, 1475 and 1423 cm
21), CLO group
(1658 cm21), carbonates COO2 group (1384 cm21), and tertiary
amine group (1291 cm21), which arise from the starting
materials (ethanol, TEOS, and PVP). As shown in Fig. S2b, ESI3,
for as-prepared MUCNCs@SNTs, the FT-IR spectrum presents
the –OH group (3440 cm21), H2O (1630 cm
21), Si–O–Si group
(vs, 1090 cm
21; vas, 808 cm
21), Si–OH group (vs, 957 cm
21), Si–
O group (d, 465 cm21) (where vs represents symmetric
stretching, vas represents asymmetric stretching, d represents
d bending).61 The MUCNCs@SNTs after calcination at 600 uC
for 3 h in air will lose the majority of silanol and absorbed
water, thus hydrophobic interaction between Si–O–Si and DOX
may play a more important role in the adsorption of DOX. The
respective N2 adsorption/desorption isotherms of
MUCNCs@SNTs are shown in Fig. S3, ESI3. It can be seen
that the silica samples show similar IV isotherms and the
typical H1-hysteresis loops, demonstrating the typical tube
structure. For the MUCNCs@SNTs, the BET surface area is
about 601.9 m2 g21, pore volume is about 0.753 cm3 g21, and
average pore size is about 5 nm.
The UC emission spectrum and UC mechanisms of the as-
prepared MUCNCs@SNTs are shown in Fig. S4, ESI3, respec-
tively. Under 980 nm NIR laser excitation, two obvious strong
emission bands centered at 656 nm and 673 nm can be
assigned to 4F9/2 A 4I15/2 transitions of Er3+ in the emission
spectra for MUCNCs@SNTs (Fig. S4a, ESI3). The up-conversion
spectrum is subject to the surface properties of Gd-doped
NaYF4:Yb/Er, and the presence of –OH groups and photonic
band gaps in the MUCNCs@SNTs result in the quenching of
green emission and enhancement of red emission.59–61 C. H.
Yan reported a novel UC photonic crystal fabricated by
embedding NaYF4:Yb/Er nanoparticles in inverse opals, and
manipulates the UC emission behavior.59 A relatively intense
red emission was observed, while the intensity of green
emission decreased sharply.62,63 The same reason may hold
for the current MUCNCs@SNTs to some extent. The UC
mechanisms in Yb3+ and Er3+ co-doped materials are well
investigated.26 Initially, Yb3+ ions are excited from 2F7/2 to
2F5/2
level by 980 nm laser, and then an excited Yb3+ transfer its
energy to Er3+ (4I11/2). Just as the electron stays on the
4I11/2
level, a second 980 nm photon excites Yb3+ ions, and then the
energy is transferred to Er3+, resulting in the electron
population on higher 4F7/2 energetic state of the Er
3+ ions.
The Er3+ ion can then relax nonradiatively by a multi-phonon
relaxation process to the 2H11/2 and
4S3/2 levels and the
dominant green 2H11/2 A 4I15/2 and 4S3/2 A 4I15/2 emissions
occur. Alternatively, the electron can further relax and
populate the 4F9/2 level resulting in the occurrence of red
4F9/2
A 4I15/2 emission. The above excitation, energy transfer and up-
conversion emission process is schematically shown in Fig. S4b,
ESI3.
The biocompatibility of the MUCNCs@SNTs
It is important to evaluate the biocompatibility of the carrier
materials for their potential biomedical applications. The
lanthanides-based UC luminescent materials have been
reported to exhibit no or low cytotoxicity in vivo in some
literatures.64–68 Here MTT assays were performed on L929 cell
lines to evaluate the cytotoxicity of our samples. As shown in
Fig. 6, MUCNCs@SNTs showed no significant cytotoxic effect
on the L929 cells at 3.125–200 mg mL21 after incubation for 24
h. The cell viability can even reach 96.49% with the
concentration as high as 200 mg mL21. The results above
demonstrate that our samples have good biocompatibility and
have potential to be used as drug carrier materials.
Drug loading and release properties of UCNCs@SNTs
We further examined the drug loading and release ability of as-
prepared MUCNCs@SNTs. Doxorubicin hydrochloride (DOX),
an anti-cancer drug, was used as a model drug to evaluate the
loading and controlled release behaviors of the tubular
composite samples. The actual loading level of DOX in the
nanotubes is calculated to be 8.36% in weight, which is
determined by the characteristic DOX optical absorbance at
480 nm. Fig. 7 gives cumulative drug release profiles for the
DOX-MUCNCs@SNTs DDS in two different pH value phos-
phoric acidic buffer solutions (PBS) over a time period of 60 h
at 37 uC. The initial burst release may be attributed to the DOX
weakly adsorbed on the outer surface of the silica nanotubes,
and the slow release of the rest of the DOX can be ascribed to
the strong interaction between DOX molecules and the silica
nanotube inner surface. Only 56.2% of the DOX is released
from the SNTs even after 60 h at pH = 7.4. In contrast, almost
90% of the DOX is released in mildly acidic conditions (pH =
5.0). The drug release behavior shows that the liberation of
DOX from MUCNCs@SNTs is pH-dependent. The surface zeta-
Fig. 6 The L929 fibroblast cells viability after incubating with MUCNCs@SNTs
for 24 h and quantitative assays by standard MTT method.
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potential of the SiO2 sample becomes more positive with the
decrease of the pH value, and the weakened electrostatic
adsorption force with positive charged DOX molecules results
in the faster drug release at low pH values.64,65 It is well known
that the extracellular pH of many solid tumors is lower than
normal tissues and presents an acidic microenvironment.66,67
As an improvement of our former work,43 SNTs have a larger
BET surface area compared with porous silica fibers, and the
N2 adsorption/desorption isotherms demonstrate the SNTs
possess cavity within the silica fiber. The tubular structure can
not only hold for drugs but also release more DOX than the
porous fiber structure in the same pH values PBS due to the
weak electrostatic adhesion between DOX and cavity. The pH-
sensitive DOX release might be beneficial at the reduced pH
values in intracellular lysosomes, endosomes and certain
cancerous tissues for targeted release and controlled therapy
at the pathological sites.68
In vitro cytotoxicity effect on cancer cells
To test the pharmacological activity of the DOX-loaded
nanotubes, the cytotoxic effect of DOX-loaded MUCNCs@SNTs
onHeLa cells is evaluated in vitro viaMTT assay. Fig. 8 shows the
cancer cell viabilities against free DOX, DOX-MUCNCs@SNTs,
and MUCNCs@SNTs for 24 h at different concentrations. The
concentration of MUCNCs@SNTs was set at the same level as
the MUCNCs@SNTs concentration used in the DOX-
MUCNCs@SNTs. The pure MUCNCs@SNTs without DOX have
no obvious cytotoxic effect on cancer cells even after 24 h of
treatment with the samples at the concentration as high as 50 mg
mL21. In contrast, both free DOX and DOX-MUCNCs@SNTs
exhibited an increasing inhibition against HeLa cells with an
increased concentration. It is found that the DOX-
MUCNCs@SNTs exhibit the similar cytotoxicity to that of free
DOX. Free DOX spread faster than the DOX-MUCNCs@SNTs by
cellular uptake. When the concentration is higher, more DOX-
MUCNCs@SNTs would be endocytosed to enter the cancer cells
and release DOX inside to introduce cell death. Therefore, we
conclude that MUCNCs@SNTs have potential to be used as a
carrier for anti-cancer drugs.
Cellular uptake and in vitro MR and UCL imaging of
MUCNCs@SNTs
MUCNCs@SNTs were ultrasonically treated before drug load-
ing and cellular uptake, and the TEM image of tubular
fragments were shown in Fig. S5, ESI3. From the TEM image, it
can be seen that the length and diameter of fragments range
from 1.5 mm to 3 mm and from 500 nm to 1 mm, respectively.
Thus, we know that the ultrasonication can cut the long tubes
(several hundred micrometers) into short ones effectively.
Fig. 8 In vitro HeLa cell viabilities after incubation 24 h with free DOX, DOX-
UCNCs@SNTs and pure UCNCs@SNTs at different concentrations.
Fig. 9 Flow cytometry analysis of the control cells (a, b) and HeLa cells incubated
with FITC-MUCNCs@SNTs for 30 min (c, d) and 6 h (e, f).
Fig. 7 Cumulative DOX release from MUCNCs@SNTs at pH = 7.4 (a) and pH =
5.0 (b).
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Since MUCNCs@SNTs were labeled with fluorescent dye, FITC,
the cell uptake degree of the composites could be quantified
with flow cytometry by determining the red fluorescence
emitted from FITC-MUCNCs@SNTs treated HeLa cells. After
incubation with the samples for different lengths of time (30
min, and 6 h), the cell-labeling ability of composites was
estimated by flow cytometry. As revealed by Fig. 9, FITC-
MUCNCs@SNTs were taken up by HeLa cells compared to the
controlled cells, and the cellular uptake of samples increase
with incubation time.
To evaluate the MR properties of MUCNCs@SNTs, an in
vitro T1-weighted MR imaging for MUCNCs@SNTs was
conducted on a Shanghai Niumag Corporation Ration
NM120-Analyst system. As shown in Fig. 10, the slope of the
plot of 1/T1 versus the Gd
3+ concentration, the ionic long-
itudinal relaxivity (R1) was determined to be 0.947 s
21 mM21.
With the increase of Gd3+ concentration, the T1-weighted MRI
resulted in brighter images (inset of Fig. 11). To obtain a clear
view of the dose-dependent positive enhancement effect,
colored T1-weighted MR images are also presented (inset of
Fig. 11). As the concentration increasing, the color of the MR
images changed from blue to red, corresponding to the signal
from low to high level. The results above demonstrated that
the composites could serve as a T1-MRI contrast agent. The
interaction of HeLa cells with the MUCNCs@SNTs was also
investigated by up-conversion luminescent microscopy
(UCLM) equipped with infrared laser excitation at 980 nm.
HeLa cells were incubated with MUCNCs@SNTs (100 mg mL21)
at 37 uC for 4 h for cell imaging (Fig. 11). Bright-field
measurements after treatment with the UCNCs@SNTs con-
firmed that the cells are viable throughout the imaging
experiments (Fig. 11a). Moreover, the red UC luminescent
signal can be observed from the HeLa cells under laser
excitation at 980 nm (Fig. 11b). Overlays of bright-field and UC
luminescent images further demonstrate that the lumines-
cence is evident in the intracellular region (Fig. 11c). This
indicates that MUCNC@SNTs penetrate the cell membrane of
HeLa cells, and confirms that MUCNC@SNTs are promising
candidates for use as bioimaging probes.
Conclusions
In summary, water-dispersible magnetic and up-conversion
luminescent NaYF4:Yb/Er/Gd NCs were synthesized by a
hydrothermal route using PEI as an organic polymer surfac-
tant. Then MUCNCs@precursor fibers were prepared by
electrospinning using precursor solution containing
MUCNCs. Finally, MUCNCs@SNTs were obtained after high
temperature annealing (600 uC), resulting in the formation of
magnetic/UC luminescent hollow silica fibers. The as-prepared
MUCNCs@SNTs show the attractive properties of regular
tubular morphology, good biocompatibility and high effective-
ness of drug release which are suitable for anti-cancer drug
(DOX) storage/release as a drug carrier. It is found that the
liberation of DOX from MUCNCs@SNTs has a pH-sensitive
release pattern. DOX is shuttled into cells by MUCNCs@SNTs
carriers and released inside cells after endocytosis, and the
DOX-MUCNCs@SNTs exhibits similar cytotoxicity to free DOX.
We also prove that the applications of MUCNCs@SNTs for
UCL and MRI multimodality in vitro imaging can be
Fig. 10 Plot of R1 (1/T1, s
21) versus Gd3+ concentration (1, 0.5, 0.25, 0.125,
0.025 mM of Gd3+). The slope indicates the specific relaxivity. Inset: the T1-
weighted and color-mapped MR images of MUCNCs@SNTs with deionized
water (0 mM) as the reference.
Fig. 11 Inverted florescence microscope images of HeLa cells incubated with UCNCs@SNTs, bright-field image (a), UC luminescent image (b) and the overlay of
bright-field and UC luminescent images (c).
8524 | RSC Adv., 2013, 3, 8517–8526 This journal is  The Royal Society of Chemistry 2013
Paper RSC Advances
Pu
bl
ish
ed
 o
n 
20
 M
ar
ch
 2
01
3.
 D
ow
nl
oa
de
d 
by
 L
ib
ra
ry
 o
f C
hi
ne
se
 A
ca
de
m
y 
of
 S
ci
en
ce
s o
n 
15
/0
3/
20
14
 0
8:
34
:3
0.
 
View Article Online
established successfully. These studies indicate that electro-
spinning is a facile and novel route for the preparation of
functionalized silica nanotube materials, which have potential
applications in the fields of drug delivery and multimodality
imaging based on their bioactive, magnetic, luminescent and
hollow properties.
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